Biotech sector highly critical of Commission's patent stand, new survey reports

Marks & Clerk has released the findings of its most recent annual survey of executives working in the biotechnology industry. Among the highlights are:
• 72% of biotech executives fear the Commission’s enquiry into the pharmaceutical sector will…

Get unlimited access to all IAM content